Abaloparatide

Abaloparatide (brand name Tymlos) is a parathyroid hormone-related protein (PTHrP) analog drug used to treat osteoporosis. Like the related drug teriparatide, it is an anabolic (i.e., bone growing) agent.[1] In 2017, it was approved to treat postmenopausal osteoporosis in the United States. Contents 1 Medical uses 2 Side effects 3 Pharmacology 4 History 4.1 Preclinical studies 4.2 Clinical Trials 5 Commercialization 5.1 Regulatory Information 5.2 Intellectual Property ... [wikipedia]